Paul O'Toole is a Professor of Microbial Genomics and Principal Investigator at the APC Microbiome Ireland, University College Cork. His research focuses on the gut microbiome's role in health, aging, and disease, particularly in the context of diet and probiotics. He leads projects like the ELDERMET study on elderly nutrition and the NU-AGE project exploring Mediterranean diets' anti-aging effects. He holds a BA (Mod.) from Trinity College Dublin and a PhD from Lund University, with postdoctoral training in Canada and New Zealand. Key grants include studies on dairy-derived microbiota, probiotic strain improvement, and microbiome analysis in aging populations. He has published extensively on Lactobacillus genomics, gut-brain interactions, and microbiome-driven health outcomes. His work bridges fundamental microbiology with clinical applications, emphasizing translational research. Scientific highlights include discovering microbiome links to cognitive decline, demonstrating dietary modulation of gut microbes to combat obesity, and identifying keystone species in healthy aging. He advocates for sustainability in conservation and food systems, reflecting his interdisciplinary approach to global health challenges.
Calliope Dendrou is an Associate Professor in Clinical Pathology and Inflammation at the Kennedy Institute of Rheumatology (KIR), University of Oxford, leading the Immune Disease Multiomics Laboratory. She previously held a Wellcome & Royal Society Sir Henry Dale Fellowship at the University of Oxford’s Centre for Human Genetics before joining KIR in 2023. Her research focuses on immune disease mechanisms using multiomics approaches, including genomic profiling to identify therapeutic targets across tissues and immune-mediated diseases. She co-leads large-scale projects like the Oxford-J&J Cartography Consortium and the Chan Zuckerberg Initiative’s LEGACY Network, and teaches on the MSc in Genomic Medicine program. Educational Background: BSc (Biology, Imperial College London, 2005; Forbes Memorial Medal Winner); PhD in Infection & Immunity (University of Cambridge, 2010). Postdoctoral training at the Weatherall Institute of Molecular Medicine under Prof. Lars Fugger. Research interests include immunogenetics, cytokine signaling pathways, drug repositioning, and cross-disease pathophysiology. Her work integrates single-cell and spatial transcriptomics to dissect immune-cell interactions in diseases like rheumatoid arthritis, inflammatory bowel disease, and celiac disease. Recent articles highlight her contributions to understanding vaccine adjuvant responses, Th17 cell roles in spondyloarthritis, and immune-epithelial networks in celiac disease. Collaborations emphasize multi-omic data analysis (e.g., Panpipes pipeline) and translational studies toward precision medicine. Awards: Forbes Memorial Medal (BSc), Wellcome & Royal Society Sir Henry Dale Fellowship. Leadership roles include Equality, Diversity, and Inclusion Champion and 'Single-Cell & Spatial Omics for Precision Medicine' Module Lead. Lab & Teams: Immune Disease Multiomics Lab at KIR. Active in collaborative initiatives such as the LEGACY Network, focusing on large-scale immune profiling in ancestrally diverse populations.
Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.
Manuel R. Amieva is a Professor at Stanford University School of Medicine , holding joint appointments in Pediatrics - Infectious Diseases and Microbiology & Immunology . He is also a member of the Maternal & Child Health Research Institute (MCHRI) . His clinical practice at Stanford Medicine Children's Health focuses on pediatric infectious diseases. Education: Medical Education: Stanford University School of Medicine (1997) Fellowship: Stanford University Pediatric Infectious Disease Fellowship (2004) Internship & Residency: Stanford Health Care at Lucile Packard Children's Hospital (1998-1999) Dr. Amieva's research investigates host-pathogen interactions at epithelial barriers, with specific expertise in Helicobacter pylori , Listeria monocytogenes , Salmonella enterica , and Staphylococcus aureus . His lab develops innovative organoid culture systems with controlled polarity to study microbial colonization and oncogenic mechanisms. Key discoveries include: H. pylori's manipulation of epithelial junctions via the CagA protein Listeria's exploitation of cell extrusion sites for invasion Staphylococcus toxin interactions with adherens junctions Gastric stem cell activation by pathogens Recent publication trends show continued leadership in infectious disease mechanisms (2020-2025), with a focus on: Pathogen-specific epithelial breach strategies Organoid modeling of viral/bacterial interactions Redox-dependent host factor regulation Single-cell spatial transcriptomic analyses Multi-institutional educational frameworks His scientific collaborations span disciplines including: Gastric cancer genomics initiatives COVID-19 lung infection models Stem cell-microbe interactions Medical education reform projects Dr. Amieva maintains active clinical research while mentoring students in both the Microbiology & Immunology and Pediatrics programs. His lab at Stanford employs advanced 3D confocal microscopy and organ-on-a-chip technologies to visualize epithelial colonization dynamics.
Rong Zheng is a Professor in the Department of Computing and Software and a member of the School of Biomedical Engineering at McMaster University, Canada. She holds a Tier-1 Canada Research Chair in Mobile Computing and serves as Acting Chair of the Computing and Software department from July to December 2025. She is also an Associate Member of the Electrical & Computer Engineering department. Education: Ph.D. in Computer Science, University of Illinois, Urbana-Champaign, USA Master of Engineering (thesis) in Electrical Engineering, Tsinghua University, Beijing, China Bachelor of Engineering in Electrical Engineering, Tsinghua University, Beijing, China Dr. Zheng's research lies at the intersection of mobile computing, wireless networking, and machine learning, with a strong focus on applications for aging populations. She directs the NSERC Smart Mobility for the Aging Population CREATE program. Her work encompasses sensor development, wireless network design, and mobile data analytics to address real-world challenges in healthcare, mobility, and data center monitoring. She has developed innovative solutions like the MacQuest campus navigation app and has captured first prize in indoor localization competitions. Her recent publications demonstrate a clear trajectory toward applying wireless sensing technologies (particularly acoustic, Wi-Fi, and mmWave) to health monitoring and mobility assessment for older adults. There's a strong emphasis on developing efficient edge computing solutions that can process data in real-time on resource-constrained devices, as exemplified by her TeamNet framework for collaborative inference on the edge. Her work bridges theoretical advances with practical applications that have social impact. Scientific Awards: Tier-1 Canada Research Chair in Mobile Computing US National Science Foundation CAREER Award (2006) Joseph Ip Distinguished Engineering Fellow (2015-2018) Dr. Zheng leads the Wireless System Research Group (WiSeR) at McMaster University, which has secured significant funding including a $1.65M NSERC CREATE grant for smart mobility research for older adults. Her research has been supported by multiple funding agencies including NSERC, NSF, UH GEAR, and DURIP. She actively mentors graduate students and has developed specialized courses including CAS 772 (Mobile Data Analytics) and CAS 781 (Mobility in the Aging Population). The WiSeR group conducts impactful research on communication, networking, and data analytics issues in Cyber Physical Systems, with applications spanning healthcare, smart infrastructure, and data center monitoring. Their work on data center infrastructure monitoring networks has been featured in EurekAlert and Data Center Dynamics, and they've made significant contributions to indoor localization technology.
Christopher M. Overall is a Full Professor at the University of British Columbia in the Faculty of Dentistry, Department of Oral Biological and Medical Sciences . He is also a Principal Scientist at the Centre for Blood Research and holds associate memberships in UBC's Biochemistry & Molecular Biology , Obstetrics and Gynecology , and Bioinformatics Graduate Program departments. As a Canada Research Chair Laureate , he pioneered the field of degradomics to study proteases in vivo. B.D.S., University of Adelaide Ph.D., University of Toronto Postdoctoral Fellowship, UBC (with Nobel Laureate Michael Smith) Dr. Overall’s research focuses on protease proteomics and systems biology , particularly degradomics to analyze protease substrates in diseases like COVID-19 and immunodeficiency . His work on matrix metalloproteinases has revealed new therapeutic strategies for inflammatory diseases and cancer . His 15 most recent articles (2015–2008) demonstrate expertise in TAILS proteomics , protein terminomics , and protease network analysis with applications in arthritis , antiviral immunity , and precision medicine . Scientific Awards 2022 Helmut Holzer Award 2018 Royal Society of Canada Fellow 2014 Tony Pawson Canadian Proteomics Award 2013 IADR Distinguished Scientist Award Dr. Overall has mentored 61 trainees , including 9 full professors with department chairs, and received the UBC John McNeill Mentorship Award (2023). He leads the HUPO Chromosome-centric Human Proteome Project and consults for Genentech and Novartis .
Timothy Webster serves as Professor of Law and Associate Dean for Faculty Research and Development at Western New England University's School of Law, with prior academic appointments at Yale Law School, Case Western Reserve University, and international institutions including University of Paris—Dauphine and National Taiwan University. His educational qualifications include: B.A., Yale University M.A., Yale University J.D., Cornell Law School LL.M., Cornell Law School Webster's research focuses on intersections between international law and East Asian domestic legal systems (China, Japan, Korea, Taiwan), examining human rights frameworks, international trade mechanisms, foreign investment regulations, and transnational litigation strategies. His scholarship demonstrates deep engagement with historical justice issues and contemporary legal challenges in the region, delivered through presentations at over 175 international conferences conducted in English, French, Japanese, and Mandarin. Analysis of his recent publications reveals consistent thematic concentration on war reparations, state immunity doctrines, corporate liability frameworks, and civil society's role in transnational redress movements, with empirical studies of litigation patterns across East Asia forming a distinctive methodological thread. His professional recognition includes: Catherine Jones Professor of the Year award (2023 and 2024) Asia Scholars Network fellowship (Luce Foundation) U.S.-Japan Network for the Future membership (Mansfield Foundation) Public Intellectuals Program selection (National Committee on U.S.-China Relations) As Associate Dean, Webster mentors law students in international legal studies while directing faculty development initiatives. His research is substantially supported by elite fellowships from the Luce Foundation, Mansfield Foundation, and National Committee on U.S.-China Relations, enabling extensive international collaboration. Webster has testified before Congress regarding China's WTO compliance and contributes legal analysis to major media outlets including The Conversation, South China Morning Post, and Los Angeles Times.
Prof. Dr. Alex Hall is an Associate Professor at the Department of Environmental Systems Science and Head of the Institute of Integrative Biology at ETH Zürich , Switzerland. He holds a PhD from the University of Edinburgh (2008), followed by postdoctoral work at the University of Oxford and ETH Zürich, including prestigious SNSF Ambizione and Marie Curie Intra-European fellowships. Research Focus: The Hall lab investigates Microbial interactions in human microbiomes Antibiotic resistance evolution Horizontal gene transfer dynamics Computational and in vitro modeling of microbial communities Evolutionary medicine applications Scientific Contributions: His recent studies analyze probiotic treatments for Staphylococcus aureus decolonization, strain-specific ecological success in gut microbiomes, and CRISPR-Cas system roles in plasmid conflicts. The lab employs computational frameworks combined with experimental validations. Scientific Awards: SNSF Ambizione fellowship Marie Curie Intra-European fellowship He also serves on the SNSF PRIMA fellowship evaluation panel and the ETH Zürich Coordination Council Medicine .
Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788
Guoyao Wu is a Distinguished Professor of Animal Nutrition at Texas A&M University's College of Agriculture & Life Sciences, holding dual appointments in the Department of Animal Science and the Graduate Faculty of Nutrition. His expertise spans nutritional biochemistry, protein metabolism, and reproductive physiology. Dr. Wu earned his B.Sc. from South China Agricultural University, M.Sc. degrees from Beijing Agricultural University and the University of Alberta, and a Ph.D. from the University of Alberta, followed by postdoctoral training at McGill University and Memorial University of Newfoundland. His research focuses on amino acid and protein metabolism across molecular, cellular, and whole-animal levels, using models like cattle, pigs, and aquatic species. Key areas include placental nutrient transport, fetal programming, and the role of amino acids in mitigating conditions like sarcopenia and intrauterine growth restriction. He has pioneered studies on glycine, creatine, and citrulline supplementation in livestock and aquaculture. Dr. Wu has received over 15 prestigious awards from China, Canada, and the U.S., including the Thousand-People-Talent Award and Changjiang Scholar Award. He serves on editorial boards of journals like Amino Acids and Frontiers in Bioscience , and teaches graduate courses in protein metabolism. His work bridges basic science and applied nutrition, with implications for improving livestock productivity, human health, and aquaculture sustainability. Current projects address amino acid requirements of companion animals, microgravity effects on metabolism, and placental biology in ruminants.
Houman Savoji is an Associate Professor in the Department of Pharmacology and Physiology at the Faculty of Medicine, University of Montreal. He is also a full-time researcher at the CHU Sainte-Justine Research Center and principal investigator in regenerative medicine, organs-on-chip, and bioprinting at TransMedTech Institute. Dr. Savoji received his PhD in Biomedical Engineering from the Institute of Biomedical Engineering at Polytechnique Montréal in 2016. He then completed a postdoctoral fellowship at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. His research expertise combines advanced manufacturing technologies (micro- and nano-fabrication, 3D bioprinting, microfluidics, cell electrospinning) with functional and composite materials for applications in tissue engineering, regenerative medicine, and organs-on-chip. His work focuses on the design, development, optimization, implementation, and characterization of innovative functional biomaterials using emerging engineering technologies, with particular emphasis on cardiac tissue engineering and biomimetic pulmonary heart valves for pediatric patients. Dr. Savoji has published extensively on biomaterials, tissue engineering, 3D bioprinting, and organ-on-chip technologies. His recent publications demonstrate expertise in viscoelastic characterization of soft tissues, engineering immune responses to biomaterials, ceramic engineering for biomedical applications, and advanced 3D bioprinting techniques for cardiac and vascular tissue engineering. 2017-2020, Postdoctoral Research Grant, CIHR 2017-2019, Postdoctoral Research Grant, FRQNT 2017-2018, Human Society of International Grant, Human Toxicity Assessment Project 2016, CR-CHUM Research Center Award 2015, Star Student-Researcher Award, FRQNT 2014-2015, Jane and Frank Warchol Fellowship, Society of Vacuum Coaters Foundation 2013, Institute of Textile Science Award 2012-2015, Excellence Doctoral Scholarship for Foreign Students, FRQNT Dr. Savoji has supervised Master's students including Ines Barrakad (2024) working on 'Advanced manufacturing technologies versus molding of corneal implants: 3D printing vs molding of a Keratoprosthesis' and Zineb Ajji (2023) researching 'Development of perfusable patches by 3D bioprinting for potential application in cardiac tissue regeneration.' He has secured numerous research grants from organizations including CIHR, NSERC, FRQNT, FRQS, MITACS, and others for projects related to 3D bioprinting of cardiac tissues, biomimetic heart valves, and other tissue engineering applications. The Savoji Laboratory, located within the Department of Pharmacology and Physiology and Institute of Biomedical Engineering of the Faculty of Medicine of the University of Montreal, the Research Center of the CHU Sainte-Justine (CHUSJ), and the TransMedTech Institute, focuses on multidisciplinary research involving 3D bioprinting using stem-cell derived human cardiac cells to fabricate functional cardiac tissues for transplantation and drug discovery applications.
Margaret Bublitz is Associate Professor at Brown University with joint appointments in the Department of Psychiatry and Human Behavior , Department of Medicine , and Department of Obstetrics and Gynecology . She holds secondary appointments at the School of Public Health as Senior Investigator and Behavioral and Social Sciences faculty member. Dr. Bublitz earned her PhD in Clinical Psychology (2010) from the University of British Columbia, followed by postdoctoral training in Cardiovascular Behavioral Medicine at Brown Medical School. Her research focuses on: Psychological stress pathways to adverse perinatal outcomes Maternal childhood maltreatment effects on neurobiology Mindfulness interventions for hypertension and preterm birth prevention Her 15 most recent publications demonstrate expertise in perinatal mental health , sleep-disordered breathing , HPA axis regulation , and fetal neurodevelopment , with significant collaborations in neuroendocrinology and maternal-infant health disparities . Scientific recognition includes: 2024-2025 Global Fulbright Scholarship 2022 Brown Early Career Research Achievement Award Multiple NIH and foundation grants exceeding $6 million Bublitz leads NIH-funded projects examining mechanisms of mindfulness training (R01HL157288) and serves as mentor in the MORPHE Trial for digital maternal health innovations. She is a licensed psychologist and active member of Brown's Stress, Trauma and Resilience (STAR) Institute and Mindfulness Center .
Dr Adam Ritchie serves as a Senior Vaccinologist at the University of Oxford's Jenner Institute and Lecturer in Human Science at St Catherine's College. His work focuses on translating academic vaccine research into real-world impact through the development, manufacture, and clinical testing of candidates for rabies, Epstein-Barr virus (EBV), and SARS-CoV-2. Education: Holds a BSc, PhD, and Fellow of the Higher Education Academy (FHEA) qualification. His research spans vaccine development, clinical trial design, regulatory affairs, and public policy through Vax-Hub Global. Key interests include adenovirus-vectored platforms, scalable manufacturing processes, and addressing global health challenges in resource-limited settings. Analysis of his 2020-2025 publications reveals a cohesive research trajectory centered on ChAdOx1-vectored vaccines. Dominant themes include prime-boost regimens, intranasal delivery systems, cost-effectiveness modeling for low-income countries, and material science applications for vaccine stabilization. His work bridges laboratory innovation with implementation science, particularly in rabies prophylaxis and pandemic response. Ritchie actively contributes to the Douglas Research Group at the Jenner Institute and global vaccine initiatives through Vax-Hub. His collaborative work appears in high-impact journals including The Lancet, Nature Medicine, and Vaccine, with emphasis on clinical translation and equitable vaccine access.
Karoline Faust is an Associate Professor at KU Leuven, affiliated with the Laboratory of Molecular Bacteriology (Rega Institute) and the Faculty of Medicine . She contributes to the iSi Health and Leuven One Health institutes, and serves on senior academic councils. Her research spans microbial systems biology, focusing on community dynamics and network analysis. Education: PhD in bioinformatics (2010, KU Leuven) Affiliations: KU Leuven, ISME Journal editorial board, Belgian Society for Microbiology Her research investigates microbial community dynamics , systems biology approaches to microbiomes, and bioinformatics tool development . She specializes in modeling human gut microbiota , synthetic microbial communities , and environmental microbiomes (e.g., microplastic impacts on Daphnia microbiomes). Her work integrates metabolic modeling , network analysis , and experimental systems to understand microbial interactions. Recent publications highlight her contributions to microbial network inference , 16S rRNA sequencing protocols , microfluidics , and ecological modeling of microbiomes. She develops tools like manta , miaSim , and CoNet to analyze community structures. Teaching: Karoline co-teaches courses in microbiology, bioinformatics, and network analysis at KU Leuven, and has contributed to international workshops on microbial network inference. Scientific Engagement: She serves as Senior Editor at ISME Journal and Secretary of the Belgian Society for Microbiology .
Dr. Manisha Kulkarni is a Professor at the School of Epidemiology and Public Health, University of Ottawa, where she holds the University Research Chair in Climate Change and Emerging Diseases. She is also the Director of the INSIGHT (Interdisciplinary Spatial Informatics for Global Health) research lab and serves as Scientific Director of the Canadian Lyme Disease Research Network (TickNet Canada). Her work spans global public health, with a focus on vector-borne and zoonotic diseases. PhD in Medical Entomology, McGill University (2006) BSc in Environmental Biology, McGill University (2001) Dr. Kulkarni's research centers on the socio-ecological determinants of infectious disease emergence, particularly malaria, Lyme disease, and West Nile virus. She applies population surveys, entomological field sampling, molecular diagnostics, and GIS to study spatio-temporal patterns and the impacts of climate change and landscape transformation on disease transmission. Her work emphasizes One Health approaches and capacity building in low-resource settings. Her recent research trends show a strong focus on geospatial modeling of vector-borne diseases, climate change adaptation, urban tick surveillance, and international collaborations in Tanzania, Benin, and Latin America. She leads interdisciplinary projects integrating drone mapping, citizen science (e.g., eTick.ca), and community participation to identify disease risk factors. Scientific awards and recognitions include: University Research Chair in Climate Change and Emerging Diseases Ontario Early Researcher Award Faculty of Medicine Award for Leadership in Global Health (2023) Researcher of the Year, Faculty of Medicine (2019) Member, College of New Scholars, Royal Society of Canada NSERC Discovery Grant and CIHR funding Dr. Kulkarni has successfully advised multiple PhD and Master’s students and leads major funded projects supported by CIHR, PHAC, CFI, IDRC, and NSERC. She has held leadership roles as Associate Dean of Global Health (2021–2024) and currently serves on the CIHR Institute of Infection and Immunity advisory board. Her lab, INSIGHT, fosters an interdisciplinary training environment combining field, lab, and analytical methods for global health research. Key research teams and collaborations include: INSIGHT Lab, University of Ottawa Pan-African Malaria Vector Research Consortium (PAMVERC) Canadian Lyme Disease Research Network (TickNet Canada) London School of Hygiene & Tropical Medicine (LSHTM) National Microbiology Lab, PHAC Centre de Recherche Entomologique de Cotonou (CREC), Benin
